Ventilatory Parameters and Inflammatory Responses of Neonates Ventilated by Different Modes of Ventilation
Determination of Ventilatory Parameters and Inflammatory Responses of Neonates Who Are Ventilated by Volume Guarantee Combined With Synchronized Intermittent Mandatory Ventilation or Pressure Support Ventilation
1 other identifier
interventional
40
1 country
1
Brief Summary
The main purpose of this study is to investigate effects of SIMV+VG (synchronized intermittent mandatory ventilation+volume guarantee) or PSV+VG (pressure support ventilation+volume guarantee) ventilation on vital signs, patient - mechanical ventilation synchrony, ventilation parameters and inflammatory mediators in neonates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2011
CompletedStudy Start
First participant enrolled
January 1, 2012
CompletedFirst Posted
Study publicly available on registry
January 23, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedNovember 20, 2013
November 1, 2013
1.8 years
December 20, 2011
November 19, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (13)
IL-1beta levels in tracheal aspirate material
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
Baseline and 72 hours of mechanical ventilation
IL-6 level in tracheal aspirate
Tracheal aspirate will be analyzed for IL6 level and the change from baseline will be reported
Baseline and 72 hours of mechanical ventilation
IL-8 in tracheal aspirate material
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
Baseline and 72 hours of mechanical ventilation
IL-10 level in tracheal aspirate material
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
Baseline and 72 hours of mechanical ventilation
TNF alfa in tracheal aspirate material
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
Baseline and 72 hours of mechanical ventilation
tidal volume variability
variability in tidal volume measured with babyview program
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
peak inspiratory pressure variability
variability in peak inspiratory pressure measured with babyview program
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
respiratory rate variability
changes in respiratory rate, tacypnea rate
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
oxygen saturation variability
changes in oxygen saturation, desaturation rate, hyperoxy rate
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
lowest carbondioxide level (mmHg)
ratio of hypocarbic blood gases and least pCo2 level
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
highest carbondioxide level (mmHg)
ratio of hypercarbic blood gases and highest pCo2 level
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
lowest oxygen level (mmHg)
ratio of hypoxic blood gases and least pO2 level
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
highest oxygen level (mmHg)
ratio of hyperoxic blood gases and highest pO2 level
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
Secondary Outcomes (8)
bronchopulmonary dysplasia
36 weeks corrected age
patent ductus arteriosus
in the first week of post natal life of the patient
necrotizing enterocolitis
36 weeks corrected age
intraventricular hemorrhage
during first week
pneumothorax
during first 3 days
- +3 more secondary outcomes
Study Arms (2)
PSV+VG
ACTIVE COMPARATORNeonates who require mechanical ventilation and randomised to pressure support + volume guarantee (PSV+VG) mode
SIMV+VG
ACTIVE COMPARATORNeonates who require mechanical ventilation and randomised to synchronised intermittant mandatory ventilation + volume guarantee (SIMV+VG) mode
Interventions
Neonates who need mechanical ventilation will be ventilated with SIMV+VG mode
Neonates who need mechanical ventilation will be ventilated with PSV+VG
Eligibility Criteria
You may qualify if:
- neonates with respiratory distress who need mechanical ventilation
- gestational age less than or equal to 37 weeks
- neonates who need mechanical ventilation within first 24 hours
You may not qualify if:
- neonates who need mechanical ventilation other than conventional ventilation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University Hospital, Department of Pediatrics, Division of Newborn Medicine
Beşevler, Ankara, 06500, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ebru N Ergenekon, MD
Gazi University, Division of newborn Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.Dr
Study Record Dates
First Submitted
December 20, 2011
First Posted
January 23, 2012
Study Start
January 1, 2012
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
November 20, 2013
Record last verified: 2013-11